Emergent has announced the expansion of our proprietary NARCANDirect™ online distribution network to include KLOXXADO® (naloxone HCl) Nasal Spray 8 mg. Read more: investors.emergentbiosolutions.com/news-releases/…

The Emergent team recently presented a poster titled “Anthrax weaponization, the availability heuristic, and public health policy preparations,” at the NBC Finland Symposium on CBRNE Threats.

Emergent has announced a contract modification to deliver one of our smallpox products to the Administration for Strategic Preparedness and Response (ASPR) for smallpox preparedness. Read more: wego.emergentbiosolutions.com/3IyJDJz

In June, our team attended the Global Health EDCTP3 Forum in Rwanda, presenting a sponsored symposium on pandemic preparedness. Learn more about what Emergent is doing to protect and save lives: wego.emergentbiosolutions.com/4nAjOZW

Toxic drug deaths, many involving fentanyl, grew in April after showing signs of decreasing in the previous two months, underscoring the ongoing need for expanded access to naloxone and other interventions. globalnews.ca/news/11259752/…

Life was chaotic for Dillon Moore at times when he was growing up, after his dad became dependent on prescription opioids to manage pain from a car accident. Read Dillon’s story: emergentbiosolutions.com/opioid-crisis/…

President and CEO of National Safety Council, Lorraine Martin, speaks about creating a work environment where a culture of safety is the top value.

We are thrilled to welcome Scott White, M.D., Emergent’s new Head of Clinical Development.

We recently partnered with Foreign Policy on the report “Resilience Without Borders: Integrating biosecurity into total defense strategies.” Read the report here: fpanalytics.foreignpolicy.com/2025/07/09/int…

Emergent’s mission is a big reason Rafael Muniz, head of medical affairs, decided to join the company.

Dvorah Richler, senior director, government affairs and market access, speaks about what Emergent’s mission to protect and save lives means to her and about the work she does to help improve public health.

.Joseph W.A. Fourre recounts the story of his son, Harlan, and explains why he is at war with fentanyl. Read more about Joseph’s story here: emergentbiosolutions.com/opioid-crisis/…

Emergent has announced the publication of a comprehensive review article on our antiviral product, in the peer-reviewed journal, Expert Review of Anti-infective Therapy. Read more: investors.emergentbiosolutions.com/news-releases/…

Scott Barnes, senior director, government affairs, shares his thoughts on the importance of his work at Emergent.

Emergent applauds the U.S. House of Representatives for adding over-the-counter naloxone to every AED location in its buildings. Read more: investors.emergentbiosolutions.com/news-releases/…

Emergent has partnered with EUCOPE and Science|Business on a report titled “Preparedness in Action: Securing Europe’s Future Against Health Emergencies.” Read the report here: sciencebusiness.net/report/securin…

B, who lost her brother and father to opioid overdose, has seen her family devastated by the opioid crisis. B tells her story to warn that opioid overdose can happen to anyone at any time.

Kathy Love-Weitz, vice president, global strategic marketing and commercial development, shares why she’s excited about her new role at Emergent.